The illuma product launched this month contains 2'Fucosyllactose (2'FL) and Lacto-N-(neo)tetraose (LNnT), which account for two of the three major types of HMOs.
Nestlé launched a milk solution containing HMOs (Human Milk Oligosaccharides) for early life nutrition in mainland China, under the Wyeth illuma brand.
This follows the recent approval for the use of such bioactives by the country's National Health Commission. The use of HMOs is propelled by numerous scientific studies that show the importance of these components in gut and immune health as well as cognitive development in infants, the company said.